search
Back to results

Mobile Neurofeedback for Low Back Pain (NINR)

Primary Purpose

Chronic Low Back Pain

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Neurofeedback
Sham (Placebo Control)
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Low Back Pain focused on measuring Neurofeedback, Biofeedback, Mobile Device, chronic low back pain, Pain Intensity, Relaxation, mHealth, Opioid

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Responding greater than 3 months to "How long has low back pain been an ongoing problem for you?" Responding 'at least half the days' to "How often has low back pain been an ongoing problem for you over the past 6 months?" Investigators will follow recommendations to items and responses provided by the NIH Task Force on Research Standards for Chronic Low Back Pain, which specifically: "recommended 2 questions to achieve the definition of chronic low back pain: (1) How long has back pain been an ongoing problem for you? (2) How often has low back pain been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1 and a response of 'at least half the days in the past 6 months' to question 2 would define chronic lower back pain." Exclusion Criteria: History of seizures. Planning pain-related surgery in the next 9 months. Individuals with implanted medical devices that could experience interference during EEG and/or ECG, such as a spinal cord stimulator or pacemaker. Lower back pain is associated with compensation or litigation issues. Rating of past week pain intensity<4 on 0-10 point scale. Rating of past week pain interference<4 on 0-10 point scale.

Sites / Locations

  • Duke University Medical Center, Department of PsychiatryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Experimental Condition

Control Condition

Arm Description

Mobile Neurofeedback intervention arm

Sham-control arm

Outcomes

Primary Outcome Measures

Change in pain intensity
Low back pain intensity on a 0-10 point rating scale, where higher scores indicate greater pain intensity.

Secondary Outcome Measures

Change in pain interference as measured by PROMIS (Patient-Reported Outcomes Measurement Information System)
A higher PROMIS T-score indicates greater pain interference. The minimum score is 8 and the maximum score is 40.
Change in physical function as measured by speed on the 50-foot walk test
Participant is timed by how long it takes for them to walk 50 feet.
Change in alpha brainwave (8 - 13 Hz) power as measured by EEG (electroencephalography)
An EEG can identify and measure the electrical activity in the brain. Higher EEG alpha brainwave power indicates a greater state of relaxation.

Full Information

First Posted
December 20, 2022
Last Updated
October 10, 2023
Sponsor
Duke University
Collaborators
National Institutes of Health (NIH), National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT05669027
Brief Title
Mobile Neurofeedback for Low Back Pain
Acronym
NINR
Official Title
Effective Self-Management of Chronic Pain With mHealth Neurofeedback
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 2, 2023 (Actual)
Primary Completion Date
May 1, 2027 (Anticipated)
Study Completion Date
May 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
National Institutes of Health (NIH), National Institute of Nursing Research (NINR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to learn more about improving the quality of treatments for people who have chronic low back pain. Participants will complete interviews with Duke researchers at four different time points: the beginning of the study, at 3 months, at 6 months, and at 9 months. Participants will be asked to use a mobile app and a headset that are designed to train the brain to be more relaxed. Participants will use the mobile app for 10 minutes at a time, four times a week for three months. The study team will also check in with participants about app use six times throughout the study, via phone or video conference.
Detailed Description
This is a double-blind randomized controlled trial to test effects of mHealth mobile neurofeedback on the outcomes of pain, enrolling 150 adult participants (18 years of age or older) with chronic low backpain. Participants will be scheduled for a baseline interview at Dr. Elbogen's research office at Duke after a preliminary telephone screen. After providing informed consent, participants will complete an eligibility assessment, a physical function test, self-report questionnaire on pain interference including clinical interviews for health outcomes of pain; self-report questionnaire on pain interference, pain self-efficacy, drug and alcohol use, opioid use, drug/alcohol use; a physical function test; and an EEG. Participants will be be randomly assigned to either an experimental (mobile neurofeedback) or placebo-control (sham neurofeedback) group. All participants will receive a portable Muse EEG headset and an iPod Touch with a mobile app named 'Mobile Neurofeedback' and be asked to complete 10-minute sessions at least 4 days per week for 12 weeks. Participants will be asked to report their current level of pain, stress, and anger before and after each session. The experimental condition involves a mobile app that provides auditory feedback signaling EEG alpha power above a threshold level, denoting a physiologically relaxed state. The control condition involves a visually identical mobile app yoked to a pre-recorded set of actual neurofeedback sessions (i.e., placebo). Study coordinators will conduct 6 check in calls in the intervening period, the study team will to reinforce training, troubleshoot technical problems, and assess any risk/safety issues (weeks 1,3,5,7,9, and 11). Follow-up data will be collected upon completion of the intervention at 12 weeks, 24 weeks and 36 weeks. During all follow-up visits, participants will complete self-report questionnaires, a physical function test, and an EEG. Data will be collected at baseline, 3, 6, and 9 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low Back Pain
Keywords
Neurofeedback, Biofeedback, Mobile Device, chronic low back pain, Pain Intensity, Relaxation, mHealth, Opioid

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Examine effects of mobile neurofeedback on changes in pain intensity, pain interference, physical function, and EEG alpha (8-13 Hz) power. Examine mediating effect of self-efficacy on changes in pain outcomes.
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental Condition
Arm Type
Experimental
Arm Description
Mobile Neurofeedback intervention arm
Arm Title
Control Condition
Arm Type
Placebo Comparator
Arm Description
Sham-control arm
Intervention Type
Device
Intervention Name(s)
Neurofeedback
Intervention Description
Participants will be asked to complete 10-minute sessions at least 4 days per week for 12 weeks. Participants will be asked to report their current level of pain, stress, and anger before and after each session. The experimental condition involves a mobile app that provides auditory feedback signaling EEG alpha power above a threshold level, denoting a physiologically relaxed state.
Intervention Type
Device
Intervention Name(s)
Sham (Placebo Control)
Intervention Description
Participants will be asked to complete 10-minute sessions at least 4 days per week for 12 weeks. Participants will be asked to report their current level of pain, stress, and anger before and after each session. The control condition involves a visually identical mobile app yoked to a pre-recorded set of actual neurofeedback sessions (i.e., placebo).
Primary Outcome Measure Information:
Title
Change in pain intensity
Description
Low back pain intensity on a 0-10 point rating scale, where higher scores indicate greater pain intensity.
Time Frame
Months 3, 6, and 9
Secondary Outcome Measure Information:
Title
Change in pain interference as measured by PROMIS (Patient-Reported Outcomes Measurement Information System)
Description
A higher PROMIS T-score indicates greater pain interference. The minimum score is 8 and the maximum score is 40.
Time Frame
Months 3, 6, and 9
Title
Change in physical function as measured by speed on the 50-foot walk test
Description
Participant is timed by how long it takes for them to walk 50 feet.
Time Frame
Months 3, 6, and 9
Title
Change in alpha brainwave (8 - 13 Hz) power as measured by EEG (electroencephalography)
Description
An EEG can identify and measure the electrical activity in the brain. Higher EEG alpha brainwave power indicates a greater state of relaxation.
Time Frame
Months 3, 6, and 9

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Responding greater than 3 months to "How long has low back pain been an ongoing problem for you?" Responding 'at least half the days' to "How often has low back pain been an ongoing problem for you over the past 6 months?" Investigators will follow recommendations to items and responses provided by the NIH Task Force on Research Standards for Chronic Low Back Pain, which specifically: "recommended 2 questions to achieve the definition of chronic low back pain: (1) How long has back pain been an ongoing problem for you? (2) How often has low back pain been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1 and a response of 'at least half the days in the past 6 months' to question 2 would define chronic lower back pain." Exclusion Criteria: History of seizures. Planning pain-related surgery in the next 9 months. Individuals with implanted medical devices that could experience interference during EEG and/or ECG, such as a spinal cord stimulator or pacemaker. Lower back pain is associated with compensation or litigation issues. Rating of past week pain intensity<4 on 0-10 point scale. Rating of past week pain interference<4 on 0-10 point scale.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Janequia Evans
Phone
919-681-1613
Email
DBHTL@duke.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Betsy Serrano
Phone
919-681-1613
Email
DBHTL@duke.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric Elbogen, Ph.D.
Organizational Affiliation
Duke - Professor in Psychiatry and Behavioral Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center, Department of Psychiatry
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eric Elbogen
Phone
919-684-9983
Email
vetstudy@duke.edu
First Name & Middle Initial & Last Name & Degree
Eric Elbogen, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mobile Neurofeedback for Low Back Pain

We'll reach out to this number within 24 hrs